 Jesse Hinckley
Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cannabis | 10 | 2023 | 384 | 3.670 |
Why?
| | Substance-Related Disorders | 5 | 2023 | 947 | 2.210 |
Why?
| | Marijuana Abuse | 2 | 2023 | 212 | 1.440 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2023 | 364 | 1.310 |
Why?
| | Motivational Interviewing | 2 | 2022 | 87 | 0.890 |
Why?
| | Hallucinogens | 2 | 2023 | 73 | 0.820 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2022 | 159 | 0.700 |
Why?
| | Fluoxetine | 1 | 2019 | 46 | 0.630 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 228 | 0.530 |
Why?
| | Marijuana Smoking | 3 | 2023 | 224 | 0.510 |
Why?
| | Blood Platelet Disorders | 1 | 2014 | 10 | 0.480 |
Why?
| | Adolescent | 12 | 2023 | 17831 | 0.470 |
Why?
| | Depression | 1 | 2019 | 1133 | 0.360 |
Why?
| | Comorbidity | 2 | 2023 | 1448 | 0.310 |
Why?
| | Mental Health | 2 | 2023 | 562 | 0.290 |
Why?
| | Legislation, Drug | 3 | 2023 | 78 | 0.290 |
Why?
| | von Willebrand Diseases | 2 | 2016 | 11 | 0.260 |
Why?
| | Humans | 18 | 2023 | 114624 | 0.230 |
Why?
| | Craving | 1 | 2023 | 32 | 0.220 |
Why?
| | Gray Platelet Syndrome | 2 | 2011 | 3 | 0.190 |
Why?
| | Vaping | 1 | 2022 | 45 | 0.180 |
Why?
| | Tobacco Products | 1 | 2022 | 98 | 0.180 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2022 | 71 | 0.180 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2020 | 30 | 0.180 |
Why?
| | Substance Abuse Detection | 1 | 2020 | 62 | 0.170 |
Why?
| | Problem Behavior | 1 | 2020 | 86 | 0.170 |
Why?
| | Empathy | 1 | 2020 | 138 | 0.160 |
Why?
| | Dronabinol | 1 | 2020 | 118 | 0.160 |
Why?
| | Analgesics | 1 | 2020 | 158 | 0.160 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 347 | 0.160 |
Why?
| | Conduct Disorder | 1 | 2020 | 193 | 0.160 |
Why?
| | Tandem Mass Spectrometry | 1 | 2020 | 411 | 0.150 |
Why?
| | Adult | 4 | 2023 | 30528 | 0.150 |
Why?
| | Suicide | 1 | 2023 | 505 | 0.140 |
Why?
| | Lipids | 1 | 2020 | 580 | 0.140 |
Why?
| | Emotions | 1 | 2020 | 472 | 0.130 |
Why?
| | Prevalence | 1 | 2022 | 2249 | 0.130 |
Why?
| | Pedigree | 5 | 2016 | 460 | 0.130 |
Why?
| | von Willebrand Factor | 1 | 2015 | 56 | 0.120 |
Why?
| | Mutant Proteins | 1 | 2015 | 95 | 0.120 |
Why?
| | Genetic Research | 1 | 2014 | 17 | 0.120 |
Why?
| | Proteomics | 1 | 2020 | 836 | 0.120 |
Why?
| | Protein Multimerization | 1 | 2015 | 157 | 0.110 |
Why?
| | Female | 8 | 2022 | 59466 | 0.110 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2013 | 6 | 0.110 |
Why?
| | Family | 2 | 2015 | 589 | 0.110 |
Why?
| | Cognition | 1 | 2020 | 988 | 0.110 |
Why?
| | History, 20th Century | 1 | 2014 | 264 | 0.110 |
Why?
| | Myelin Proteolipid Protein | 1 | 2013 | 61 | 0.110 |
Why?
| | Colorado | 1 | 2022 | 4099 | 0.100 |
Why?
| | Hemorrhage | 1 | 2016 | 620 | 0.100 |
Why?
| | United States | 3 | 2023 | 12176 | 0.100 |
Why?
| | Cytoplasmic Granules | 1 | 2011 | 82 | 0.090 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2011 | 49 | 0.090 |
Why?
| | Microarray Analysis | 1 | 2011 | 118 | 0.090 |
Why?
| | Pregnancy | 1 | 2022 | 5517 | 0.090 |
Why?
| | Biomarkers | 1 | 2020 | 3408 | 0.090 |
Why?
| | Male | 7 | 2020 | 55555 | 0.080 |
Why?
| | Chromosome Mapping | 1 | 2011 | 487 | 0.080 |
Why?
| | Genetic Loci | 1 | 2011 | 262 | 0.080 |
Why?
| | Blood Proteins | 1 | 2011 | 231 | 0.080 |
Why?
| | Young Adult | 2 | 2022 | 10455 | 0.080 |
Why?
| | Blood Platelets | 1 | 2011 | 351 | 0.080 |
Why?
| | Nerve Tissue Proteins | 1 | 2011 | 529 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2014 | 2084 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 1879 | 0.050 |
Why?
| | Mutation | 1 | 2013 | 3344 | 0.050 |
Why?
| | Electronics | 1 | 2022 | 67 | 0.050 |
Why?
| | Phenotype | 2 | 2016 | 2796 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2023 | 2387 | 0.040 |
Why?
| | Amish | 1 | 2016 | 7 | 0.030 |
Why?
| | Indiana | 1 | 2016 | 26 | 0.030 |
Why?
| | Wisconsin | 1 | 2016 | 91 | 0.030 |
Why?
| | Parents | 1 | 2023 | 1186 | 0.030 |
Why?
| | Point Mutation | 1 | 2016 | 216 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2015 | 101 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2015 | 402 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2015 | 293 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2015 | 591 | 0.030 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 796 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2011 | 152 | 0.020 |
Why?
| | Sex Factors | 1 | 2016 | 1715 | 0.020 |
Why?
| | Genes, Recessive | 1 | 2011 | 73 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2011 | 353 | 0.020 |
Why?
| | Risk Factors | 1 | 2023 | 8628 | 0.020 |
Why?
| | Homozygote | 1 | 2011 | 187 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2011 | 294 | 0.020 |
Why?
| | Protein Binding | 1 | 2015 | 1889 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2011 | 455 | 0.020 |
Why?
| | Age Factors | 1 | 2016 | 2894 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2011 | 723 | 0.020 |
Why?
| | Phylogeny | 1 | 2011 | 789 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2114 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2011 | 1982 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2011 | 2785 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 4405 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2016 | 5043 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2016 | 6344 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2016 | 4620 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2011 | 3003 | 0.010 |
Why?
| | Infant | 1 | 2016 | 7959 | 0.010 |
Why?
| | Child, Preschool | 1 | 2016 | 9108 | 0.010 |
Why?
| | Aged | 1 | 2016 | 19061 | 0.010 |
Why?
| | Child | 1 | 2016 | 18404 | 0.010 |
Why?
| | Middle Aged | 1 | 2016 | 26719 | 0.010 |
Why?
|
|
Hinckley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|